YINLIN JACK CHEN

Insider Reports History

Location
South San Francisco, CA
Signature
/s/Lillian Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by YINLIN JACK CHEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. SVP, Finance Stock Option (Right to Buy) 39,160 $376,719 $9.62 10 Aug 2023 Direct
Allogene Therapeutics, Inc. SVP, Finance Common Stock 88,881 $282,144 $3.17 10 Aug 2023 Direct

Insider Reports Filed by YINLIN JACK CHEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALLO Allogene Therapeutics, Inc. 10 Aug 2023 2 $0 4 SVP, Finance 14 Aug 2023, 20:59
ALLO Allogene Therapeutics, Inc. 10 Aug 2023 0 $0 3 SVP, Finance 14 Aug 2023, 20:28